Recap: IDEAYA Biosciences Q4 Earnings
Portfolio Pulse from Benzinga Insights
IDEAYA Biosciences (NASDAQ:IDYA) reported Q4 earnings with an EPS of $-0.52, missing estimates by 10.64% compared to the expected $-0.47. Revenue decreased by $99 thousand from the same period last year. In the previous quarter, the company beat EPS estimates which led to a 5.67% increase in share price the following day.
February 20, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IDEAYA Biosciences reported lower than expected Q4 earnings and a decrease in revenue compared to last year, missing EPS estimates by 10.64%.
Missing earnings estimates typically leads to negative investor sentiment in the short term, especially when coupled with a year-over-year revenue decrease. Given the company's history of stock price increase following a positive earnings surprise last quarter, this miss may lead to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100